Fundraising Fox

Sofinnova Ventures2026 Investments

5 investments dated 2026 · listed companies and verified rows first · show all

Quanta Therapeuticsquantatx.comJun 2026 · $50M

Quanta is a biotech company developing orally bioavailable, CNS-penetrant small-molecule KRAS inhibitors targeting RAS-driven cancers such as pancreatic, colorectal, lung, and endometrial cancers.

BiotechDeep TechHealthtechSouth San Francisco, US

Cameron Pitt(Executive Officer, Director)Ying Huang(Director)Derek Metzger(Executive Officer)

BoardPerry Nisen(Executive Officer, Director)Maria Fardis(Director)

Board seatMaha Katabi· per SEC Form D

Co-investorsLongitude CapitalVida VenturesBiotechnology Value FundFrazier Life Sciences

Route 92 Medicalr92m.comin𝕏Jan 2026SEC filingmedium confidence

Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment.

BiotechHardwareHealthtechMedical DevicesSan Mateo, US

Dr. Chou(Founder & Chief Executive Officer)Cindy Lynch(Executive Officer)Tony Chou(Executive Officer, Director)in

BoardJack Lasersohn(Director)inTamir Meiri(Director)Jonathan Root(Director)in

Board seatNoel Jee· per SEC Form D · $50M raise · filed Apr 2026

Co-investorsNorwest Venture PartnersRunway Growth CapitalUS Venture PartnersThe Vertical Group

Apollo Health Venturesapollo.vcin𝕏Jan 2026

Apollo is a venture capital firm that invests in life-science and biotechnology startups, combining entrepreneurial expertise with deep scientific knowledge to support early-stage companies in drug development and personalized medicine.

BiotechDeep TechHealthtechLongevity

Nils Regge(Co-Founder & General Partner)in

Co-investorsBLN CapitalCoastCapFJ LabsKfW CapitalTruVenturo GmbHCTI Life Sciences Fund L.P.+3 more

Coultreoncoultreon.cominApr 2026 · $125M

Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.

AI & Machine LearningBiotech

Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)Marie De Vulder(Chief Legal Officer Co-founder)Guy Peeters(Chief Financial Officer Co-founder)John-Paul Gallivan(Head of Development Co-founder)Fabrice Kolb(Head of Immunology Co-founder)Pieter Peeters(Operating & Technology Officer Co-founder)

Co-investorsLongwood FundBAM ElevateFinchley Healthcare VenturesForbionLuma GroupNovo Holdings+1 more

Sensei BiotherapeuticsFeb 2026

BiotechRockville, US

Kristian Humer(Director)Christopher Gerry(Executive Officer, Director)Anand Kiran Parikh(Executive Officer, Director)Josiah Craver(Executive Officer)

BoardBob Holmen(Director)Phillip B. Donenberg(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.